The pentose phosphate pathway in developing chick cornea

Quercetin modulates keratoconus metabolism in vitro

Corneal scarring is the result of a disease, infection or injury. The resulting scars cause significant loss of vision or even blindness. To-date, the most successful treatment is corneal transplantation, but it does not come without side effects. One of the corneal dystrophies that are correlated with corneal scarring is keratoconus (KC). The onset of the disease is still unknown; however, altered cellular metabolism has been linked to promoting the fibrotic phenotype and therefore scarring. We have previously shown that human keratoconus cells (HKCs) have altered metabolic activity when compared to normal human corneal fibroblasts (HCFs). In our current study, we present evidence that quercetin, a natural flavonoid, is a strong candidate for regulating metabolic activity of both HCFs and HKCs in vitro and therefore a potential therapeutic to target the altered cellular metabolism characteristic of HKCs. Targeted mass spectrometry-based metabolomics was performed on HCFs and HKCs with and without quercetin treatment in order to identify variations in metabolite flux. Overall, our study reveals a novel therapeutic target OF Quercetin on corneal stromal cell metabolism in both healthy and diseased states. Clearly, further studies are necessary in order to dissect the mechanism of action of quercetin.

Ultraviolet light-induced changes in the glucose-6-phosphate dehydrogenase activity of porcine corneas

PURPOSE

Corneas have the high activity of the pentose phosphate pathway. To clarify the relevance of the pentose phosphate pathway to their antioxidant defense, we examined the activity of glucose-6-phosphate dehydrogenase (G6PDH), the rate-determining enzyme of the pathway, in corneas exposed to ultraviolet light (UV).

METHODS

Fresh porcine eye globes were exposed to ultraviolet light A (UVA) or ultraviolet light C (UVC), and the tear film-removed eye globes to UVA. After UV exposure, the corneas were dissected from the eye globes and extracted with a saline solution, and the G6PDH activity in the extract was assayed. The G6PDH activity of unilateral opaque corneas, their paired, transparent corneas, and normal corneas, all of which were obtained from fresh, UV-unexposed eye globes, and the L-lactate dehydrogenase (LDH) activity of these opaque and normal corneas also were assayed.

RESULTS

The G6PDH activity of corneas increased with UVA exposure, and decreased with long-term UVC exposure, although it increased with short-term UVC exposure. A UV-blocking contact lens screened corneas from the UVA-induced increase. Removal of the tear film enhanced the UVC-induced decrease. The G6PDH activity of unilateral opaque corneas was lower than that of paired, transparent corneas or normal corneas, all of which were obtained from fresh, UV-unexposed eye globes. The LDH activity of the opaque corneas was much higher than that of the normal corneas.

CONCLUSION

Exposure of corneas to UVA or a small dose of UVC enhances the G6PDH activity, i.e., the pentose phosphate pathway. This activity enhancement may play an important role in corneal antioxidant defense against UV-induced oxidative stress. However, exposure of corneas to large doses of UVC appears to damage the pathway.

Heterogeneous expression of transketolase in ocular tissues

PURPOSE

Previous studies have shown that transketolase is preferentially expressed in the corneal epithelium and comprises up to 10% of the soluble protein of the mature mouse cornea. The aim of this study is to evaluate the expression and distribution of TKT in the different ocular tissues.

METHODS

We have used in situ hybridization and immunohistochemistry to localize TKT mRNA and protein in the developing and adult mouse eye.

RESULTS

TKT were found to be widely distributed throughout the adult mouse eye. Among the ocular tissues examined, the corneal epithelium exhibited the highest levels of TKT mRNA and protein. Within the epithelial layer, TKT mRNA and protein were differentially distributed with the highest expression occurring in basal cells and the lowest in apical cells, suggesting that TKT expression in the corneal epithelium may be differentiation-related. Enriched expression of TKT was also found in the cornea endothelium, lens epithelium, ciliary body, and iris. Low basal levels of expression were observed in the limbus and conjunctiva. In contrast to the adult eye, TKT expression in the one-day-old mouse eye was homogeneous at low, but detectable levels, suggesting that TKT expression is developmentally regulated in the cornea as well as in the other ocular tissues. In the healing corneal epithelium, TKT expression in the single cell layer of the leading edge was completely suppressed until the cells began to stratify, at which point TKT expression increased markedly.

CONCLUSIONS

The results presented here suggest that TKT is differentially expressed and developmentally regulated in the various tissues that comprise the eye.

Transketolase is a major protein in the mouse cornea

Earlier experiments in this laboratory identified a highly expressed 65-68-kDa protein in both mouse and human corneas (Cuthbertson, R. A. , Tomarev, S. I., and Piatigorsky J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4004-4008). Here, we demonstrate that this protein is transketolase (TKT; EC 2.2.1.1), an enzyme in the nonoxidative branch of the pentose-phosphate pathway, based on peptide and cDNA isolation and sequence analysis of mouse cornea protein and RNA samples, respectively. While expressed at low levels in a number of tissues, the 2.1-kilobase TKT mRNA was expressed at a 50-fold higher level in the adult mouse cornea. The area of most abundant expression was localized to the cornea epithelial cell layer by in situ hybridization. Western blot analysis confirmed TKT protein abundance in the cornea and indicated that TKT may comprise as much as 10% of the total soluble protein of the adult mouse cornea. Soluble cornea extracts exhibited a correspondingly high level of TKT enzymatic activity. TKT expression increased progressively through cornea maturation, as shown by Northern blot, in situ hybridization, Western blot, and enzymatic analyses. TKT mRNA and protein were expressed at low levels in the cornea prior to eye opening, while markedly increased levels were observed after eye opening. Taken together, these observations suggest that TKT may be a cornea enzyme-crystallin, and suggest that the crystallin paradigm and concept of gene sharing, once thought to be restricted to the lens, apply to other transparent ocular tissues.